602 related articles for article (PubMed ID: 22314603)
21. Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies.
Scully M; Cataland S; Coppo P; de la Rubia J; Friedman KD; Kremer Hovinga J; Lämmle B; Matsumoto M; Pavenski K; Sadler E; Sarode R; Wu H;
J Thromb Haemost; 2017 Feb; 15(2):312-322. PubMed ID: 27868334
[TBL] [Abstract][Full Text] [Related]
22. Thrombotic microangiopathy: differential diagnosis, pathophysiology and therapeutic strategies.
Mayer SA; Aledort LM
Mt Sinai J Med; 2005 May; 72(3):166-75. PubMed ID: 15915311
[TBL] [Abstract][Full Text] [Related]
23. Thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome.
Moake JL
Arch Pathol Lab Med; 2002 Nov; 126(11):1430-3. PubMed ID: 12421153
[TBL] [Abstract][Full Text] [Related]
24. von Willebrand factor-cleaving protease (ADAMTS-13) activity determination in the diagnosis of thrombotic microangiopathies: the Swiss experience.
Kremer Hovinga JA; Studt JD; Alberio L; Lämmle B
Semin Hematol; 2004 Jan; 41(1):75-82. PubMed ID: 14727262
[TBL] [Abstract][Full Text] [Related]
25. Deficiency of ADAMTS13 in thrombotic thrombocytopenic purpura.
Tsai HM
Int J Hematol; 2002 Aug; 76 Suppl 2():132-8. PubMed ID: 12430913
[TBL] [Abstract][Full Text] [Related]
26. The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring.
Mannucci PM; Cugno M
Thromb Res; 2015 Nov; 136(5):851-4. PubMed ID: 26386489
[TBL] [Abstract][Full Text] [Related]
27. Advances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura.
Tsai HM
J Am Soc Nephrol; 2003 Apr; 14(4):1072-81. PubMed ID: 12660343
[TBL] [Abstract][Full Text] [Related]
28. Thrombosis, Microangiopathies, and Inflammation.
Matevosyan K; Sarode R
Semin Thromb Hemost; 2015 Sep; 41(6):556-62. PubMed ID: 26276936
[TBL] [Abstract][Full Text] [Related]
29. The D173G mutation in ADAMTS-13 causes a severe form of congenital thrombotic thrombocytopenic purpura. A clinical, biochemical and in silico study.
Lancellotti S; Peyvandi F; Pagliari MT; Cairo A; Abdel-Azeim S; Chermak E; Lazzareschi I; Mastrangelo S; Cavallo L; Oliva R; De Cristofaro R
Thromb Haemost; 2016 Jan; 115(1):51-62. PubMed ID: 26272487
[TBL] [Abstract][Full Text] [Related]
30. What's new in the diagnosis and pathophysiology of thrombotic thrombocytopenic purpura.
Sadler JE
Hematology Am Soc Hematol Educ Program; 2015; 2015(1):631-6. PubMed ID: 26637781
[TBL] [Abstract][Full Text] [Related]
31. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.
Tsai HM; Lian EC
N Engl J Med; 1998 Nov; 339(22):1585-94. PubMed ID: 9828246
[TBL] [Abstract][Full Text] [Related]
32. [The role of von Willebrand protease in aetiopathogenesis of thrombotic thrombocytopenic purpura].
Suvajdzić-Vuković N
Srp Arh Celok Lek; 2007; 135(5-6):360-6. PubMed ID: 17633329
[TBL] [Abstract][Full Text] [Related]
33. Thrombotic thrombocytopenic purpura associated with von Willebrand factor-cleaving protease (ADAMTS13) deficiency in children.
Loirat C; Veyradier A; Girma JP; Ribba AS; Meyer D
Semin Thromb Hemost; 2006 Mar; 32(2):90-7. PubMed ID: 16575683
[TBL] [Abstract][Full Text] [Related]
34. Thrombotic thrombocytopenic purpura: pathogenesis, diagnosis and potential novel therapeutics.
Saha M; McDaniel JK; Zheng XL
J Thromb Haemost; 2017 Oct; 15(10):1889-1900. PubMed ID: 28662310
[TBL] [Abstract][Full Text] [Related]
35. Thrombotic thrombocytopenic purpura: survival by "giving a dam".
Moake JL
Trans Am Clin Climatol Assoc; 2004; 115():201-19. PubMed ID: 17060968
[TBL] [Abstract][Full Text] [Related]
36. Von Willebrand factor-cleaving protease (ADAMTS-13) activity in thrombotic microangiopathies: diagnostic experience 2001/2002 of a single research laboratory.
Studt JD; Kremer Hovinga JA; Alberio L; Bianchi V; Lämmle B
Swiss Med Wkly; 2003 Jun; 133(23-24):325-32. PubMed ID: 12923683
[TBL] [Abstract][Full Text] [Related]
37. Pathogenesis of thrombotic thrombocytopenic purpura.
Raife TJ
Curr Hematol Rep; 2003 Mar; 2(2):133-8. PubMed ID: 12901144
[TBL] [Abstract][Full Text] [Related]
38. The role of ADAMTS13 in the pathogenesis of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
George JN
Clin Adv Hematol Oncol; 2005 Aug; 3(8):627-32. PubMed ID: 16167049
[TBL] [Abstract][Full Text] [Related]
39. Thrombotic thrombocytopenic purpura-what is new?
Shah N; Sarode R
J Clin Apher; 2013 Feb; 28(1):30-5. PubMed ID: 23420593
[TBL] [Abstract][Full Text] [Related]
40. Thrombotic thrombocytopenic purpura related to severe ADAMTS13 deficiency in children.
Loirat C; Girma JP; Desconclois C; Coppo P; Veyradier A
Pediatr Nephrol; 2009 Jan; 24(1):19-29. PubMed ID: 18574602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
